VIRIDIAN THERAPEUTICS INC's ticker is VRDN and the CUSIP is 92790C104. A total of 59 filers reported holding VIRIDIAN THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,010,017 | -35.5% | 1,369,623 | 0.0% | 2.53% | -45.0% |
| Q2 2023 | $32,583,331 | -6.5% | 1,369,623 | 0.0% | 4.59% | -23.3% |
| Q1 2023 | $34,843,209 | -12.9% | 1,369,623 | 0.0% | 5.99% | -5.6% |
| Q4 2022 | $40,006,688 | +42.4% | 1,369,623 | 0.0% | 6.35% | +28.5% |
| Q3 2022 | $28,091,000 | +157.2% | 1,369,623 | +45.1% | 4.94% | +97.5% |
| Q2 2022 | $10,923,000 | -37.4% | 944,092 | 0.0% | 2.50% | -39.4% |
| Q1 2022 | $17,456,000 | -6.5% | 944,092 | 0.0% | 4.13% | -32.9% |
| Q4 2021 | $18,665,000 | +20.2% | 944,092 | 0.0% | 6.15% | +9.0% |
| Q3 2021 | $15,530,000 | +2319.0% | 944,092 | +2590.3% | 5.65% | +2039.0% |
| Q2 2021 | $642,000 | +10.5% | 35,092 | 0.0% | 0.26% | +7.8% |
| Q1 2021 | $581,000 | – | 35,092 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 2,699,865 | $78,863,057 | 13.28% |
| COMMODORE CAPITAL LP | 2,020,166 | $59,009 | 8.89% |
| ACUTA CAPITAL PARTNERS, LLC | 396,500 | $11,581,765 | 7.13% |
| Fairmount Funds Management LLC | 1,369,623 | $40,006,688 | 6.35% |
| Paradigm Biocapital Advisors LP | 1,751,167 | $51,151,588 | 6.00% |
| Vivo Capital, LLC | 1,678,207 | $49,020 | 5.64% |
| TCG Crossover Management, LLC | 983,610 | $28,731,248 | 5.07% |
| Kynam Capital Management, LP | 1,034,697 | $30,223,499 | 4.64% |
| Octagon Capital Advisors LP | 824,200 | $24,074,882 | 3.75% |
| Logos Global Management LP | 1,000,000 | $29,210,000 | 3.42% |